SensoDetect specialises in the development of equipment used to analyse the reaction of sound stimulus in the brain of a patient. The technology is mainly used in psychiatry when treating patients to distinguish potential mental disorders. The product consists of electrodes that are attached to the head of the patient to analyse brain activity. The results are compared against a database for further analysis. SensoDetect was founded in 2005 and is based in Lund.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Nordnet Pensionsförsäkring | 8,31 | 8,31 | 2022-12-28 |
| Thomas Erik Frithiof Holmgren | 6,34 | 6,34 | 2022-12-28 |
| Avanza Pension | 5,77 | 5,77 | 2022-12-28 |
| Scandinavian Medicon Invest AB | 5,13 | 5,13 | 2022-12-28 |
| Johan Möllerström med bolag | 3,38 | 3,38 | 2022-09-14 |
| Aaro Pellervo Nurkkala | 3,08 | 3,08 | 2022-12-28 |
| Tore Robertsson | 2,85 | 2,85 | 2022-12-28 |
| Birgitta Möllerström | 2,27 | 2,27 | 2022-12-28 |
| Karl Vilhelm Gustaf Lundin | 2,23 | 2,23 | 2022-12-28 |
| Handelsbanken Liv Försäkring AB | 2,18 | 2,18 | 2022-12-28 |
2023-02-24 Bokslutskommuniké 2022